AI assistant
Accenture plc — Director's Dealing 2021
Jun 30, 2021
29813_dirs_2021-06-30_d8196c02-5b4a-4605-aaf0-16a00fe6139a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Accenture plc (ACN)
CIK: 0001467373
Period of Report: 2021-06-28
Reporting Person: Ollagnier Jean-Marc (Chief Executive - Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-28 | Class A ordinary shares | S | 348 | $293.0567 | Disposed | 172422 | Direct |
| 2021-06-28 | Class A ordinary shares | S | 203 | $293.8157 | Disposed | 172219 | Direct |
| 2021-06-28 | Class A ordinary shares | S | 1 | $294.66 | Disposed | 172218 | Direct |
| 2021-06-28 | Class A ordinary shares | S | 29 | $295.755 | Disposed | 172189 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A ordinary shares | 25000 | Indirect |
| Class A ordinary shares | 6659 | Indirect |
Footnotes
F1: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan.
F2: The transaction was executed in multiple trades at prices ranging from $292.53 to $293.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The transaction was executed in multiple trades at prices ranging from $293.60 to $294.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: Class A Ordinary Shares are held by a personal holding company over which Mr. Ollagnier has investment control.